The role of transcription and growth factors in the development of the tumor pathology of the prostate gland
- Authors: Spirina L.V1,2, Kovaleva I.V2, Fedotov D.A2, Gorbunov A.K1, Usynin E.A1, Slonimskaya E.M1,2, Kondakova I.V1, Dyakov D.A2
-
Affiliations:
- Cancer Research Institute, Tomsk National Research Medical Center
- Siberian State Medical University
- Issue: Vol 17, No 6 (2019)
- Pages: 44-48
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113175
- DOI: https://doi.org/10.29296/24999490-2019-06-08
- ID: 113175
Cite item
Abstract
Keywords
Full Text
About the authors
L. V Spirina
Cancer Research Institute, Tomsk National Research Medical Center; Siberian State Medical University
Email: spirinalvl@mail.ru
Kooperativny street, 5, Tomsk, 634050, Russian Federation; Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
I. V Kovaleva
Siberian State Medical University
Email: spirinalvl@mail.ru
Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
D. A Fedotov
Siberian State Medical University
Email: spirinalvl@mail.ru
Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
A. K Gorbunov
Cancer Research Institute, Tomsk National Research Medical Center
Email: spirinalvl@mail.ru
Kooperativny street, 5, Tomsk, 634050, Russian Federation
E. A Usynin
Cancer Research Institute, Tomsk National Research Medical Center
Email: spirinalvl@mail.ru
Kooperativny street, 5, Tomsk, 634050, Russian Federation
E. M Slonimskaya
Cancer Research Institute, Tomsk National Research Medical Center; Siberian State Medical University
Email: spirinalvl@mail.ru
Kooperativny street, 5, Tomsk, 634050, Russian Federation; Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
I. V Kondakova
Cancer Research Institute, Tomsk National Research Medical Center
Email: spirinalvl@mail.ru
Kooperativny street, 5, Tomsk, 634050, Russian Federation
D. A Dyakov
Siberian State Medical University
Email: spirinalvl@mail.ru
Moskovsky trakt, 2, Tomsk, 634050, Russian Federation
References
- Austin D.C., Strand D.W, Love H.L., Franco O.E., Jang A., Grabowska M.M., Miller N.L., Hameed O., Clark P.E., Fowke J.H., Matusik R.J., Jin R.J. NF-kB and androgen receptor variant expression correlate with human BPH progression. Prostate. 2015;
- Meyer A.R., Gorin M.A. First point-of-care PSA test for prostate cancer detection. Nat. Rev Urol. 2019. https://doi. org/10.1038/s41585-019-0179-1
- Albuquerque G.A.M., Guglielmetti G.B., Barbosa A., Pontes J., Fazole A., Cordeiro M., Coelho R., Carvalho P.A., Gallucci F., Padovani J., Park R., Cury J., Nonemacher H., Srougi M., Nahas W. Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer. Rev. Assoc. Med. Bras. 2017; 63 (8): 704-10. http:// dx.doi.org/10.1590/1806-9282.63.08.704.
- Kim H.J., Park J.W, Cho Y.S., Cho C.H., Kim J.S., Hyun-Woo Shin, Chung D.H., Kim S.J., Chun Y.S. Pathogenic role of HIF-1a in prostate hyperplasia in the presence of chronic inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2013; 1832 (1): 183-94. https://doi. org/10.1016/j.bbadis.2012.09.002.
- Deep G., Panigrahi G.K. Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment. Crit Rev Oncog. 2015; 20 (5-6): 419-34. https://doi.org/10.1615/CritRevOn-cog.v20.i5-6.130.
- Chen Y, Xu H., Shi Q., Gu M., Wan X., Chen Q.,Wang Z. Hypoxia-inducible factor 1a (HIF-1a) mediates the epithelial-mesenchymal transition in benign prostatic hyperplasia. Int. J. Clin. Exp. Pathol. 2019; 12 (1): 295-304.
- Kruslin B., Tomas D., Dzombeta T, Milkovic-Perisa M., Ulamec M. Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach. Front Oncol. 2017; 7: 77. https://doi.org/10.3389/ fonc.2017.00077
- Verzella D., Fischietti M., Capece D., Vecchiotti D., Del Vecchio F., Cicciarelli G., Mastroiaco V, Tessitore A., Alesse E., Zazzeroni F. Targeting the NF-kB pathway in prostate cancer: a promising therapeutic approach. Curr. Drug Targets. 2016; 17 (3): 311-20.
- Jain G., Voogdt C., Tobias A., Spindler K.-D., Moller P, Cronauer M.V., Marienfeld R.B. IkB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines. Neoplasia. 2012; 14: 178-89. https:// doi.org/10.1593/neo.111444.
- Mehraein-Ghomi F., Church D.R., Schreiber C.L., Weichmann A.M., Basu H.S., Wilding G. Inhibitor of p52 NF-kB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR (ser81). Genes Cancer. 2015; 6: 428-44. https://doi. org/10.18632/genesandcancer.77
- Jin R.J., Lho Y, Connelly L., Wang Y, Yu X., Saint Jean L, Case T.C., Ellwood-Yen K., Sawyers C.L., Bhowmick N.A., Blackwell T.S., Yull F.E., Matusik R.J. The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth. Cancer Res. 2008; 68 (16): 6762-9. https://doi.org/10.1158/0008-5472. CAN-08-0107
- Nelius T, Filleur S., Yemelyanov A., Budunova I., Shroff E., Mirochnik Y, Aurora A., Veliceasa D., Xiao W, Wang Z., Volpert O.V. Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo. Int. J. Cancer. 2007; 121: 999-1008. https://doi.org/10.1002/ijc.22802
- Lessard L., Saad F, Le Page C., Diallo J.-S., Peant B., Delvoye N., Mes-Masson A.-M. NF-kappaB2 processing and p52 nuclear accumulation after androgenic stimulation of LNCaP prostate cancer cells. Cell. Signal. 2007; 19: 1093-100. https://doi. org/10.1016/j.cellsig.2006.12.012
- Cui Y, Nadiminty N., Liu C., Lou W, Schwartz C.T., Gao A.C. Upregulation of glucose metabolism by NF-kB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells. Endocr. Relat. Cancer. 2014; 21 (3): 435-42. https:// doi.org/10.1530/ERC-14-0107
- Wu F, Ding S., Li X., Wang H., Liu S., Wu H., Bi D., Ding K., Lu J. Elevated expression of HIF-la in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia. Oncotarget. 2016;
- Huang M., Du H., Zhang L., Che H., Liang C. The association of HIF-1a expression with clinicopathological significance in prostate cancer: a meta-analysis. Cancer Manag Res. 2018; 10: 2809-16. https://doi. org/10.2147/CMAR.S161762
- Grivas N., Goussia A., Stefanou D., Giannakis D. Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer. Cent. European J. Urol. 2016; 69 (1): 63-71. https://doi.org/10.5173/ceju.2016.726
- Cansino J.R., Vera R., Rodriguez de Bethen-court F, Bouraoui Y, Rodriguez G., Prieto A., de la Pena J., Paniagua R., Royuela M. Prostate specific antigen and NF-kB in prostatic disease: relation with malignancy. Actas. Urol. Esp. 2011; 35 (1): 16-21. https:// doi.org/10.1016/j.acuro.2010.08.002
- Gautam K.A., Singh A.N, Srivastav A.N., Sankhwar S.N. Angiogenesisinprostate-cancerandbenignprostatichyperpla-siaassessedby VEGF and CD-34 IHC: A comparative clinico-pathological study. Afr. J. Urol. 2018; 24 (2): 98-103.
- Спирина Л.В., Тарасенко Н.В., Горбунов А.К., Кондакова И.В., Слонимская Е.М., Усынин Е.А. Экспрессия молекулярных маркеров в ткани рака предстательной железы: связь с клиникоморфологическими особенностями заболевания. Медицинская генетика. 2018; 17 (3): 18-22.
- Спирина Л.В., Горбунов А.К., Кондакова И.В., Слонимская Е.М., Усынин Е.А., Тарасенко Н.В. Экспрессия транскрипционного фактора TRIM16 в ткани рака предстательной железы, связь с экспрессией эстрогеновых и андрогеновых рецепторов и клиникоморфологическими особенностями заболевания. Бюллетень сибирской медицины. 2018; 17 (3): 122-30. https://doi. org:10.20538/1682-0363-2018-3-122-130
- Staal J., Beyaert R. Inflammation and NF-kB signaling in prostate cancer: mechanisms and clinical implications. Cells. 2018; 7 (9). https://doi.org/10.3390/ cells7090122.
- Ambrosio M. R., Di Serio C., Danza G., Rocca B.J., Ginori A., Prudovsky I., Marchionni N., Del Vecchio M.T., Tarantini F Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer. Diagn Pathol. 2016; 11 (1): 45. https://doi. org/10.1186/s13000-016-0495-1
- Smyth L.G., O'Hurley G., O'Grady A., Fitzpatrick J.M., Kay E., Watson R.W. Carbonic anhydrase IX expression in prostate cancer. Prostate Cancer Prostatic Dis. 2010; 13 (2): 178-81. https://doi.org/10.1038/ pcan.2009.58